For: | Lucke-Wold B, Rangwala BS, Shafique MA, Siddiq MA, Mustafa MS, Danish F, Nasrullah RMU, Zainab N, Haseeb A. Focus on current and emerging treatment options for glioma: A comprehensive review. World J Clin Oncol 2024; 15(4): 482-495 [PMID: 38689623 DOI: 10.5306/wjco.v15.i4.482] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v15/i4/482.htm |
Number | Citing Articles |
1 |
Lei Li, Jiang-hua Yang, Xin-meng Fa, Ming-song Liu, Qi-lin Wang, Tong-fei Zeng, Rui-zhe Chen, Jun Ou, Xue-wei Xia. Preliminary investigation of nitric oxide release from upconverted nanoparticles excited at 808 nm near-infrared for brain tumors. Heliyon 2024; 10(13): e33576 doi: 10.1016/j.heliyon.2024.e33576
|
2 |
Yan Li, Fanjing Jiang, Suhua Zhu, Hongwei Jia, Changwei Li. STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1419072
|
3 |
George B. H. Green, Alexis N. Cox-Holmes, Anna Claire E. Potier, Gillian H. Marlow, Braden C. McFarland. Modulation of the Immune Environment in Glioblastoma by the Gut Microbiota. Biomedicines 2024; 12(11): 2429 doi: 10.3390/biomedicines12112429
|
4 |
Muhammad Khan, Xiuting Huang, Xiaoxin Ye, Donghui Zhang, Baiyao Wang, Anan Xu, Rong Li, Anbang Ren, Chengcong Chen, Jingjing Song, Rong Zheng, Yawei Yuan, Jie Lin. Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2405079
|